| 1 | MRNA | Moderna, Inc. | 5.21% |
| 2 | UTHR | United Therapeutics Corporation | 4.14% |
| 3 | ALKS | Alkermes plc | 4.10% |
| 4 | GILD | Gilead Sciences, Inc. | 4.09% |
| 5 | AXSM | Axsome Therapeutics, Inc. | 4.03% |
| 6 | CORT | Corcept Therapeutics Incorporated | 3.93% |
| 7 | AMGN | Amgen Inc. | 3.80% |
| 8 | EXEL | Exelixis, Inc. | 3.59% |
| 9 | ARGX | argenx SE | 3.54% |
| 10 | KRYS | Krystal Biotech, Inc. | 3.44% |
| 11 | NBIX | Neurocrine Biosciences, Inc. | 3.38% |
| 12 | REGN | Regeneron Pharmaceuticals, Inc. | 3.36% |
| 13 | VRTX | Vertex Pharmaceuticals Incorporated | 3.36% |
| 14 | BMRN | BioMarin Pharmaceutical Inc. | 3.33% |
| 15 | BIIB | Biogen Inc. | 3.29% |
| 16 | SRPT | Sarepta Therapeutics, Inc. | 3.25% |
| 17 | ONC | BeOne Medicines AG | 3.23% |
| 18 | HALO | Halozyme Therapeutics, Inc. | 3.23% |
| 19 | BNTX | BioNTech SE | 3.21% |
| 20 | INCY | Incyte Corporation | 3.16% |
| 21 | ILMN | Illumina, Inc. | 3.06% |
| 22 | NTRA | Natera, Inc. | 3.02% |
| 23 | TECH | Bio-Techne Corporation | 2.95% |
| 24 | ACAD | ACADIA Pharmaceuticals Inc. | 2.94% |
| 25 | GMAB | Genmab A/S | 2.88% |
| View FBT holdings |
